End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
23.33 CNY | +2.06% |
|
+5.04% | -7.09% |
01-29 | BCHT Biotechnology to Acquire 33% of Chuanxin Biopharma | MT |
10-25 | Changchun BCHT Biotechnology Co. Reports Earnings Results for the Nine Months Ended September 30, 2024 | CI |
P/E ratio (N) | Price to Book (N) | PEG (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Yield (N) | Capi.($) | ||
---|---|---|---|---|---|---|---|---|---|
13.97x | 2.14x | 0.37x | - | - | - | 0.7% | 1.32B | ||
20.98x | 2.12x | 7.12x | 3.21x | 11.2x | 17.56x | 1.67% | 63.01B | ||
16.24x | 1.3x | -1.19x | 1.61x | 6.96x | 8.54x | 2.73% | 7.33B | ||
16.89x | 14.74x | 0.28x | 8.54x | 13.9x | 16.06x | - | 7.26B | ||
83.27x | 5.07x | -8.84x | 4.9x | 62.28x | 103.35x | 0.31% | 7.05B | ||
151.02x | 28.01x | -0.5x | 18.5x | 100.2x | 118.23x | -.--% | 6.89B | ||
45.83x | 4.27x | 0.88x | 8.41x | 24.54x | 47.6x | 0.48% | 3.32B | ||
13.52x | 1.17x | 0.22x | - | - | - | 0.85% | 2.16B | ||
36.57x | - | 0.01x | - | - | - | - | 2.12B | ||
13.07x | -4.68x | 0x | 0.84x | 3.06x | 3.35x | -.--% | 1.19B | ||
14.23x | 0.75x | 2.5x | - | - | - | 2.43% | 1.05B | ||
-87.38x | 5x | 0.44x | - | - | - | - | 1.03B | ||
24.89x | 0.9x | 0.49x | 1.59x | 14.06x | 20.71x | - | 720M | ||
-25.27x | - | 0.45x | 13.7x | -24.2x | -21.19x | - | 616M | ||
Average | 24.13x | 5.07x | 0.16x | 6.81x | 23.55x | 34.91x | percentage-no-prefix | 7.51B | |
Weighted average by Cap. | 32.47x | 4.88x | 3.66x | 4.89x | 21.23x | 30.73x | percentage-no-prefix |
- Stock Market
- Equities
- 688276 Stock
- Sector Changchun BCHT Biotechnology Co.
- Sector valuations

MarketScreener is also available in this country: United States.
Switch edition